Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss

NCT07382544 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Solid Tumor

Interventions

DRUG: MRTX1719
DRUG: Olaparib

Sponsor

M.D. Anderson Cancer Center